Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Apr. 30, 2011
Apr. 30, 2010
Apr. 30, 2011
Apr. 30, 2010
Income Statement [Abstract]        
Net revenue $ 3,192,248 $ 3,713,585 $ 6,780,806 $ 6,781,795
Cost of revenue 1,585,179 1,422,884 3,334,544 2,728,863
Gross profit 1,607,069 2,290,701 3,446,262 4,052,932
Operating expenses        
Research and development 392,423 455,173 811,321 932,186
Selling, general and administrative expenses 925,377 1,788,406 2,705,527 3,363,300
Total operating expenses 1,317,800 2,243,579 3,516,848 4,295,486
Operating income (loss) 289,269 47,122 (70,586) (242,554)
Other income (expense)        
Other income, net 141,979 27,962 178,379 37,945
Interest expense (488,949) (454,802) (908,067) (896,384)
Amortization of deferred financing costs (60,532) (121,064)
Gain (loss) on change in fair value of derivative liability 63,308 (5,188,334) 337,212 (3,633,426)
Gain (loss) on sale of investment in marketable securities 15,750 15,750
Total other expense (283,662) (5,659,956) (392,476) (4,597,179)
Income (loss) before income taxes 5,608 (5,612,834) (463,062) (4,839,733)
Provision for income taxes
Net income (loss) applicable to Common Shares $ 5,608 $ (5,612,834) $ (463,062) $ (4,839,733)
Income (loss) per share, basic and diluted $ 0.00 $ (0.11) $ (0.01) $ (0.10)
Weighted average shares outstanding 74,039,867 49,050,244 72,824,432 49,029,133
Comprehensive loss:        
Net income (loss) $ 5,608 $ (5,612,834) $ (463,062) $ (4,839,733)
Foreign currency translation adjustment (927,580) (145,925) (306,474) (204,206)
Unrealized gain on investment 38,250 12,750
Comprehensive loss $ (921,972) $ (5,720,509) $ (769,536) $ (5,031,189)